Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Novartis
Novartis
AstraZeneca
On Target Laboratories, LLC
George Washington University
Vanderbilt-Ingram Cancer Center
Tongji Hospital
Groupe Francais De Pneumo-Cancerologie
Korea University Guro Hospital
University Medical Center Groningen
Prisma Health-Midlands
Galvanize Therapeutics, Inc.
University Medical Center Groningen
Radboud University Medical Center
Samsung Medical Center
Tongji University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Odense University Hospital
Bristol-Myers Squibb
Kaohsiung Medical University Chung-Ho Memorial Hospital
RenJi Hospital
Assistance Publique Hopitaux De Marseille
National Institute for Tuberculosis and Lung Diseases, Poland
Chonnam National University Hospital
Montefiore Medical Center
Peter MacCallum Cancer Centre, Australia
Assiut University
Laval University
Zunyi Medical College
Shanghai Chest Hospital
Icahn School of Medicine at Mount Sinai
Fuda Cancer Hospital, Guangzhou
China Medical University, China
China Medical University, China
Quadras Scientific Solutions
M.D. Anderson Cancer Center
Celgene
Fujian Medical University Union Hospital
VA Greater Los Angeles Healthcare System
University of Kansas Medical Center
Beijing Zheng Ju Medical Technology Co., Ltd.
Weill Medical College of Cornell University
National Guard Health Affairs
University of Zurich
Novartis
Fox Chase Cancer Center
Chinese Society of Lung Cancer
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Cantonal Hospital of St. Gallen
Centre Hospitalier Universitaire de Saint Etienne